201 related articles for article (PubMed ID: 34643448)
1. Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19.
Miller EH; Annavajhala MK; Chong AM; Park H; Nobel YR; Soroush A; Blackett JW; Krigel A; Phipps MM; Freedberg DE; Zucker J; Sano ED; Uhlemann AC; Abrams JA
Microbiol Spectr; 2021 Oct; 9(2):e0005521. PubMed ID: 34643448
[TBL] [Abstract][Full Text] [Related]
2. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
[TBL] [Abstract][Full Text] [Related]
4. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences.
Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J
mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423
[TBL] [Abstract][Full Text] [Related]
5. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.
Wu Y; Cheng X; Jiang G; Tang H; Ming S; Tang L; Lu J; Guo C; Shan H; Huang X
NPJ Biofilms Microbiomes; 2021 Jul; 7(1):61. PubMed ID: 34294722
[TBL] [Abstract][Full Text] [Related]
6. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19.
Schult D; Reitmeier S; Koyumdzhieva P; Lahmer T; Middelhoff M; Erber J; Schneider J; Kager J; Frolova M; Horstmann J; Fricke L; Steiger K; Jesinghaus M; Janssen KP; Protzer U; Neuhaus K; Schmid RM; Haller D; Quante M
Gut Microbes; 2022; 14(1):2031840. PubMed ID: 35174781
[TBL] [Abstract][Full Text] [Related]
7. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340
[TBL] [Abstract][Full Text] [Related]
8. Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients.
Mostafa HH; Fissel JA; Fanelli B; Bergman Y; Gniazdowski V; Dadlani M; Carroll KC; Colwell RR; Simner PJ
mBio; 2020 Nov; 11(6):. PubMed ID: 33219095
[TBL] [Abstract][Full Text] [Related]
9. Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults.
Armstrong AJS; Horton DB; Andrews T; Greenberg P; Roy J; Gennaro ML; Carson JL; Panettieri RA; Barrett ES; Blaser MJ
EBioMedicine; 2023 Aug; 94():104731. PubMed ID: 37487417
[TBL] [Abstract][Full Text] [Related]
10. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
To KK; Tsang OT; Leung WS; Tam AR; Wu TC; Lung DC; Yip CC; Cai JP; Chan JM; Chik TS; Lau DP; Choi CY; Chen LL; Chan WM; Chan KH; Ip JD; Ng AC; Poon RW; Luo CT; Cheng VC; Chan JF; Hung IF; Chen Z; Chen H; Yuen KY
Lancet Infect Dis; 2020 May; 20(5):565-574. PubMed ID: 32213337
[TBL] [Abstract][Full Text] [Related]
11. Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients.
Lai CKC; Cheung MK; Lui GCY; Ling L; Chan JYK; Ng RWY; Chan HC; Yeung ACM; Ho WCS; Boon SS; Chan PKS; Chen Z
Microbiol Spectr; 2022 Dec; 10(6):e0219622. PubMed ID: 36350127
[TBL] [Abstract][Full Text] [Related]
12. Dysbiosis of saliva microbiome in patients with oral lichen planus.
Yu FY; Wang QQ; Li M; Cheng YH; Cheng YL; Zhou Y; Yang X; Zhang F; Ge X; Zhao B; Ren XY
BMC Microbiol; 2020 Apr; 20(1):75. PubMed ID: 32245419
[TBL] [Abstract][Full Text] [Related]
13. Oral Microbiome in HIV-Infected Women: Shifts in the Abundance of Pathogenic and Beneficial Bacteria Are Associated with Aging, HIV Load, CD4 Count, and Antiretroviral Therapy.
Lewy T; Hong BY; Weiser B; Burger H; Tremain A; Weinstock G; Anastos K; George MD
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):276-286. PubMed ID: 29808701
[TBL] [Abstract][Full Text] [Related]
14. Assessing saliva microbiome collection and processing methods.
Armstrong AJS; Parmar V; Blaser MJ
NPJ Biofilms Microbiomes; 2021 Nov; 7(1):81. PubMed ID: 34795298
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Infection is Associated with Age- and Gender-Specific Changes in the Nasopharyngeal Microbiome.
Bozza S; Nunzi E; Frias-Mazuecos A; Pieraccini G; Pariano M; Renga G; Mencacci A; Talesa VN; Antognelli C; Puccetti P; Romani L; Costantini C
Front Biosci (Landmark Ed); 2024 Feb; 29(2):59. PubMed ID: 38420819
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition.
Braun T; Halevi S; Hadar R; Efroni G; Glick Saar E; Keller N; Amir A; Amit S; Haberman Y
Sci Rep; 2021 Apr; 11(1):8922. PubMed ID: 33903709
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection.
Shi YL; He MZ; Han MZ; Gui HY; Wang P; Yu JL; Ge YL; Sun Y; Huang SH
Front Cell Infect Microbiol; 2022; 12():824578. PubMed ID: 35372134
[TBL] [Abstract][Full Text] [Related]
18. New insights into diversity of the upper respiratory tract microbiota and its relationship with SARS-CoV-2 viral load in the nasopharyngeal epithelial cells in patients with COVID-19.
Talaga-Ćwiertnia K; Sroka-Oleksiak A; Zapała B; Salamon D; Krawczyk A; Brzychczy-Włoch M; Gosiewski T
Pol Arch Intern Med; 2023 Aug; 133(7-8):. PubMed ID: 36826810
[TBL] [Abstract][Full Text] [Related]
19. Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights.
Nagy-Szakal D; Couto-Rodriguez M; Wells HL; Barrows JE; Debieu M; Butcher K; Chen S; Berki A; Hager C; Boorstein RJ; Taylor MK; Jonsson CB; Mason CE; O'Hara NB
Microbiol Spectr; 2021 Oct; 9(2):e0019721. PubMed ID: 34468193
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the oral microbiome of individuals with a healthy oral environment following COVID-19 vaccination.
Uehara O; Abiko Y; Nagasawa T; Morikawa T; Hiraki D; Harada F; Kawano Y; Toraya S; Matsuoka H; Paudel D; Shimizu S; Yoshida K; Asaka M; Furuichi Y; Miura H
BMC Oral Health; 2022 Mar; 22(1):50. PubMed ID: 35241064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
